Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer
Krithika Krishnarao(Ochsner Health System), Mohamad H. Yamani(WinnMed), Jordan Ray(Mayo Clinic in Florida), Katelyn A. Bruno(Mayo Clinic in Florida), Emily R. Whelan(Mayo Clinic in Florida), Logan P. Macomb(Mayo Clinic in Florida), Xochiquetzal J. Geiger(WinnMed), Anneliese R. Hill(Mayo Clinic in Florida), Lauren Cornell(Jacksonville College), Brandy Edenfield(Mayo Clinic in Florida), Erika J. Douglass(Mayo Clinic in Florida), DeLisa Fairweather(Mayo Clinic), Damian N. Di Florio(Mayo Clinic), Winston Tan(Mayo Clinic in Florida), Gary R. Salomon(Mayo Clinic in Florida), Molly M. McGuire(Mayo Clinic in Florida)
Cited by 13
Related Papers
Sex Differences in Autoimmune Disease from a Pathological Perspective
|American Journal Of Pathology|2008|623
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
|Journal of Clinical Investigation|2020|485
Safety Update
|Mayo Clinic Proceedings|2020|432